Press Releases

28/02 Moderna : Transcript (MRNA USQ Transcript 2026 01 13 3) PU
18/02 Moderna says the FDA will consider its new flu shot after resolving a public dispute AQ
14/02 Moderna : Earnings Transcript (MRNA USQ Transcript 2026 02 13) PU
13/02 Moderna : Earnings Presentation (ModernaQ25inal) PU
13/02 Moderna: Q4 Earnings Snapshot AQ
04/02 Defiance Launches MRNX: The First Daily 2X Long ETF for Moderna, Inc. AQ
20/01 Moderna : Transcript (MRNA USQ Transcript 2026 01 13) PU
13/01 Moderna : Presentation (Moderna 2026 JPM Presentation 16 FINAL for web upload 78 ) PU
12/01 Moderna : Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference PU
17/12 Moderna : to Present at the 44th Annual J.P. Morgan Healthcare Conference PU
12/12 Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance AQ
11/12 Nanexa and Moderna enter into license and option agreement for the development of PharmaShell®-based products AQ
24/11 Moderna : Transcript (MRNA USQ Transcript 2025 11 20 2) PU
21/11 Moderna : Presentation (Moderna 2025 Analyst Day FINAL PDF 48 54e4e7af) PU
20/11 Moderna : Presentation (Moderna 2025 Analyst Day FINAL PDF 48 ) PU
20/11 Moderna : Secures $1.5 Billion Five-Year Credit Facility from Ares Management PU
07/11 Moderna : Transcript (MRNA USQ Transcript 2025 11 06 1) PU
06/11 Moderna : Presentation (Moderna 3Q25 Earnings Presentation) PU
06/11 Moderna: Q3 Earnings Snapshot AQ
27/25/27 Moderna : Transcript (MRNA USQ Transcript 2025 10 17) PU
23/25/23 Moderna : ID Week (Norovirus mRNA-1403 Phase 1 / 2 immunogenicity) PU
23/25/23 Moderna : ID Week (Lyme mRNA 1982 & 1975 safety & immunogenicity) PU
21/25/21 Moderna : ID Week (CMV mRNA-1647 in patients who have undergone hematopoietic cell transplant) PU
21/25/21 Moderna : ID Week (RSV vaccine mRNA-1345 in solid organ transplant recipients) PU
21/25/21 Moderna : ID Week (Pandemic flu mRNA-1018 safety and immunogenicity) PU
No results for this search